COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 795: Articles 7941-7950  | Next

An S1 subunit vaccine and combination adjuvant (COVAC-1) elicits robust protection against SARS-CoV-2 challenge in African green monkeys
Garnett, L., Tran, K., Chan, M., Tierney, K., Schiffman, Z., Audet, J., Lew, J., Meilleur, C., Chan, M., Manguiat, K., Tailor, N., Vendramelli, R., Deschambault, Y., Beaudoin-Bussieres, G., Bourassa, C., Richard, J., Finzi, A., Higgins, R., van den Hurk, S., Gerdts, V., Strong, J., Falzarano, D.
10.1101/2022.06.16.496375 — Posted: 2022-06-17
Nirmatrelvir plus ritonavir for early COVID-19 and hospitalization in a large US health system
Dryden-Peterson, S., Kim, A., Kim, A. Y., Caniglia, E. C., Lennes, I., Patel, R., Gainer, L., Dutton, L., Donahue, E., Gandhi, R. T., Baden, L. R., Woolley, A. E.
10.1101/2022.06.14.22276393 — Posted: 2022-06-16
Quantifying Inequities in COVID-19 Vaccine Distribution Over Time by social vulnerability, race and ethnicity, and location: A Population-Level Analysis in St. Louis and Kansas City, Missouri
Mody, A., Bradley, C., Redkar, S., Fox, B., Eshun-Wilson, I., Hlatshwayo, M. G., Trolard, A., Tram, K. H., Filiatreau, L., Thomas, F., Haslam, M., Turabelidze, G., Sanders-Thompson, V., Powderly, W. G., Geng, E. H.
10.1101/2022.06.13.22276312 — Posted: 2022-06-16
Predictive performance of multi-model ensemble forecasts of COVID-19 across European nations
Sherratt, K., Gruson, H., Grah, R., Johnson, H., Niehus, R., Prasse, B., Sandman, F., Deuschel, J., Wolffram, D., Abbott, S., Ullrich, A., Gibson, G., Ray, E. L., Reich, N. G., Sheldon, D., Wang, Y., Wattanachit, N., Wang, L., Trnka, J., Obozinski, G., Sun, T., Thanou, D., Pottier, L., Krymova, E., Barbarossa, M. V., Leithauser, N., Mohring, J., Schneider, J., Wlazlo, J., Fuhrmann, J., Lange, B., Rodiah, I., Baccam, P., Gurung, H., Stage, S., Suchoski, B., Budzinski, J., Walraven, R., Villanueva, I., Tucek, V., Smid, M., Zajicek, M., Perez Alvarez, C., Reina, B., Bosse, N. I., Meakin, S., Alaimo Di Loro, P., Maruotti, A., Eclerova, V., Kraus, A., Kraus, D., Pribylova, L., Dimitris, B., Li, M. L., Saksham, S., Dehning, J., Mohr, S., Priesemann, V., Redlarski, G., Bejar, B., Ardenghi, G., Parolini, N., Ziarelli, G., Bock, W., Heyder, S., Hotz, T., E. Singh, D., Guzman-Merino, M., Aznarte, J. L., Morina, D., Alonso, S., Alvarez, E., Lopez, D., Prats, C., Burgard, J. P., Rodloff, A., Zimmermann, T., Kuhlmann, A., Zibert, J., Pennoni, F., Divino, F., Catala, M., Lovison, G., Giudici, P., Tarantino, B., Bartolucci, F., Jona Lasinio, G., Mingione, M., Farcomeni, A., Srivastava, A., Montero-Manso, P., Adiga, A., Hurt, B., Lewis, B., Marathe, M., Porebski, P., Venkatramanan, S., Bartczuk, R., Dreger, F., Gambin, A., Gogolewski, K., Gruziel-Slomka, M., Krupa, B., Moszynski, A., Niedzielewski, K., Nowosielski, J., Radwan, M., Rakowski, F., Semeniuk, M., Szczurek, E., Zielinski, J., Kisielewski, J., Pabjan, B., Holger, K., Kheifetz, Y., Scholz, M., Bodych, M., Filinski, M., Idzikowski, R., Krueger, T., Ozanski, T., Bracher, J., Funk, S.
10.1101/2022.06.16.22276024 — Posted: 2022-06-16
Development and Evaluation of RT-LAMP Assays to Identify Variants of SARS-CoV-2
Park, G.-S., Kim, S.-J., Maeng, J.-S.
10.1101/2022.06.16.496383 — Posted: 2022-06-16
Course and clinical severity of the SARS-CoV-2 Omicron variant infection in Tianjin, China
Ren, Y., Shi, L., Xie, Y., Wang, C., Zhang, W., Wang, F., Sun, H., Huang, L., Wu, Y., Xing, Z., Ren, W., Heinrich, J., Wu, Q., Zhengcun, P.
10.1101/2022.06.16.22271932 — Posted: 2022-06-16
Prevalence and severity of symptoms 3 months after infection with SARS-CoV-2 compared to test-negative and population controls in the Netherlands
van der Maaden, T., Mutubuki, E., de Bruijn, S., Leung, K. Y., Knoop, H., Slootweg, J., Tulen, A. D., Wong, A., van Hoek, A. J., Franz, E., van den Wijngaard, C. C.
10.1101/2022.06.15.22276439 — Posted: 2022-06-16
Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study
The OpenSAFELY Collaborative, , Parker, E. P., Tazare, J., Hulme, W. J., Bates, C., Beale, R., Carr, E. J., Cockburn, J., Curtis, H. J., Fisher, L., Green, A. C., Harper, S., Hester, F., Horne, E. M., Loud, F., Lyon, S., Mahalingasivam, V., Mehrkar, A., Nab, L., Parry, J., Santhakumaran, S., Steenkamp, R., Sterne, J. A., Walker, A. J., Williamson, E. J., Willicombe, M., Zheng, B., Goldacre, B., Nitsch, D., Tomlinson, L. A.
10.1101/2022.06.14.22276391 — Posted: 2022-06-16
Two-Step Machine Learning to Diagnose and Predict Involvement of Lungs in COVID-19 and Pneumonia using CT Radiomics
Moradi Khaniabadi, P., Bouchareb, Y., Al-Dhuhli, H., Shiri, I., Al-Kindi, F., Moradi Khaniabadi, B., Zaidi, H., Rahmim, A.
10.1101/2022.06.15.22276090 — Posted: 2022-06-16
A Systematic Review on COVID-19 Vaccine preferences using Discrete Choice Experiments
AMANI, A., SELENGUAI, H. K., PUEPI, Y. D., DAIROU, I. A., KENMOE, S., NOUKO, A., CHEUYEM, F. Z. L., NGO UM, S. S., KOKI, P. O. N., MBACHAM, W., ONGOLO-ZOGO, P.
10.1101/2022.06.12.22276299 — Posted: 2022-06-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).